Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZFHX3 | hg38_v1_chr16_-_73048104_73048136 | -0.75 | 7.4e-07 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 18.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 10.8 | GO:0051005 | negative regulation of phospholipase activity(GO:0010519) negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 10.8 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 8.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
2.2 | 6.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
1.4 | 5.6 | GO:0052047 | positive regulation of fibrinolysis(GO:0051919) interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.8 | 4.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.7 | 4.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 3.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 3.4 | GO:0002576 | platelet degranulation(GO:0002576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 18.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 13.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 12.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.8 | 5.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.2 | 4.7 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 4.5 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.5 | 4.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 3.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 3.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 18.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
2.7 | 10.8 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 10.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 8.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.8 | 6.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.9 | 5.6 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.5 | 4.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 4.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 4.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.9 | 3.4 | GO:0008431 | vitamin E binding(GO:0008431) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 18.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 10.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 9.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 7.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 3.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 20.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 10.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 8.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 6.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 5.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 4.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |